文献速递神经肿瘤

激光间质热疗治疗新诊断胶质母细胞瘤预后因素的队列研究

A Cohort Study on Prognostic Factors for Laser Interstitial Thermal Therapy Success in Newly Diagnosed Glioblastoma.
PubMed 文献 · Neurosurgery · 2021-01-01

该回顾性队列研究纳入20例接受激光间质热疗(LITT)的新诊断胶质母细胞瘤(nGBM)患者,分析消融范围(EOA)和化疗时间(TTC)对总生存(OS)与无进展生存(PFS)的预测作用。结果显示EOA>70%与PFS改善显著相关,总激光功率是EOA的显著预测因素,术后16天内开始化疗可显著改善PFS。

核心结论

  • 增加EOA是LITT治疗nGBM中PFS改善的预测因素,并有OS改善趋势。
  • 倾向于使用更高激光功率的策略可能实现最佳EOA。
  • LITT后早期转为化疗可改善PFS。

研究设计与样本

  • 回顾性队列研究,纳入20例接受LITT的新诊断胶质母细胞瘤患者。
  • 收集人口学、临床和生存数据,通过基于MRI的体积分析计算EOA。
  • 采用Kaplan-Meier和多因素Cox回归分析EOA与OS、PFS的关系,并校正年龄、IDH1突变、MGMT超甲基化等协变量。
  • 通过线性回归分析激光热力学参数(功率、能量、时间)对EOA的影响。

主要发现

  • 整个队列中位OS为36.2个月,中位PFS为3.5个月。

临床怎么用

  • LITT治疗nGBM时,应争取实现EOA>70%以改善PFS。
  • 可考虑采用更高激光功率的策略以达成最佳EOA。
  • LITT术后应尽早(16天内)启动化疗以改善PFS。

局限性

  • 回顾性研究,样本量仅20例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laser interstitial thermal therapy (LITT) is a promising approach for cytoreduction of deep-seated gliomas. However, parameters contributing to treatment success remain unclear. OBJECTIVE: To identify extent of ablation (EOA) and time to chemotherapy (TTC) as predictors of improved overall and progression-free survival (OS, PFS) and suggest laser parameters to achieve optimal EOA. METHODS: Demographic, clinical, and survival data were collected retrospectively from 20 patients undergoing LITT for newly diagnosed glioblastoma (nGBM). EOA was calculated through magnetic resonance imaging-based volumetric analysis. Kaplan-Meier and multivariate Cox regression were used to examine the relationship between EOA with OS and PFS accounting for covariates (age, isocitrate dehydrogenase-1 (IDH1) mutation, O6-methylguanine-DNA methyltransferase hypermethylation). The effect of laser thermodynamic parameters (power, energy, time) on EOA was identified through linear regression. RESULTS: Median OS and PFS for the entire cohort were 36.2 and 3.5 mo respectively. Patient's with >70% EOA had significantly improved PFS compared to ≤70% EOA (5.2 vs 2.3 mo, P = .01) and trended toward improved OS (36.2 vs 11 mo, P = .07) on univariate and multivariate analysis. Total laser power was a significant predictor for increased EOA when accounting for preoperative lesion volume (P = .001). Chemotherapy within 16 d of surgery significantly predicted improved PFS compared to delaying chemotherapy (9.4 vs 3.1 mo, P = .009). CONCLUSION: Increased EOA was a predictor of improved PFS with evidence of a trend toward improved OS in LITT treatment of nGBM. A strategy favoring higher laser power during tumor ablation may achieve optimal EOA. Early transition to chemotherapy after LITT improves PFS.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Di L, Wang CP, Shah AH, et al. A Cohort Study on Prognostic Factors for Laser Interstitial Thermal Therapy Success in Newly Diagnosed Glioblastoma. Neurosurgery. 2021. PMID: 34156076. doi:10.1093/neuros/nyab193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。